Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: BML Investment Partners, L.P.

April 27, 2026 7:26 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage ownership is based on 139,663,680 shares outstanding as disclosed by the Issuer on form DEF 14A filed on 4/23/26.


SCHEDULE 13G



BML Investment Partners, L.P.
Signature:Braden M Leonard
Name/Title:BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Date:04/27/2026

Comments accompanying signature: BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.

Categories

SEC Filings